Rabenda-IT Capsule PR
Marketer
Arrient Healthcare Pvt Ltd
Salt Composition
Rabeprazole (20mg) + Itopride (150mg)
Overview Rabenda-IT Capsule PR
Gastroesophageal reflux disease (GERD) and peptic ulcer symptoms, including heartburn, stomach pain, and discomfort, are addressed by the combined medication in Rabenda-IT Capsule PR. This formulation neutralizes stomach acid and facilitates gas expulsion for enhanced relief. Dosage and duration should strictly adhere to your physician's instructions, varying depending on individual response and condition severity. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common, typically transient, side effects include abdominal pain, altered bowel habits (diarrhea or constipation), headache, gas, fatigue, and increased salivation. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid activities requiring alertness until the medication's impact is known. Alcohol consumption should be avoided due to potential increased sedation. Lifestyle adjustments, such as consuming cool milk and avoiding stimulants like coffee, tea, spicy food, and chocolate, can augment treatment effectiveness. Prior to commencing treatment, disclose any liver conditions, pregnancy, pregnancy plans, or breastfeeding to your healthcare provider.
Primary Ingredients of Rabenda-IT Capsule PR
No information provided. Therefore, no text can be rewritten.
Uses of Rabenda-IT Capsule PR
Heartburn and ulcers (GERD, peptic ulcers)
Major Benefits of Rabenda-IT Capsule PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Take Rabenda-IT Capsule PR on an empty stomach.
Common Side effects of Rabenda-IT Capsule PR:
- Stomach pain
- Diarrhea
- Constipation
- Headache
- Dizziness
- Flatulence
- Weakness
- Flu-like symptoms
- Increased saliva production
- Insomnia (difficulty in sleeping)
- Back pain
How to use Rabenda-IT Capsule PR:
Follow your doctor's instructions or consult the product label for proper usage. Take Rabenda-IT Capsule PR on an empty stomach.
How Rabenda-IT Capsule PR works:
Rabenda-IT Capsule PR combines rabeprazole, a proton pump inhibitor (PPI), with itopride, a prokinetic agent. Rabeprazole diminishes stomach acid production, easing symptoms of acid indigestion and heartburn. Itopride's action on the brain's vomiting center and the upper gastrointestinal tract accelerates stomach and intestinal motility, facilitating smoother food passage.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rabenda-IT Capsule PR and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Using Rabenda-IT Capsule PR during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Rabenda-IT Capsule PR use while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Taking Rabenda-IT Capsule PR might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Rabenda-IT Capsule PR use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Rabenda-IT Capsule PR. Dosage modification of Rabenda-IT Capsule PR may be necessary. Physician consultation is advised.
What if you forget to take Rabenda-IT Capsule PR :
Should you forget a dose of Rabenda-IT Capsule PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabenda-IT Capsule PR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Gastrointestinal system |



